EGETIS THERAPEUTICS
DEAD

Serial Number

79312278

Owner

Egetis Therapeutics AB

Filing Date

Mar 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EGETIS THERAPEUTICS Trademark

Serial Number: 79312278

EGETIS THERAPEUTICS is a trademark filed by Egetis Therapeutics AB on March 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Egetis Therapeutics AB (2 trademarks)

Grev Turegatan 11c, 3tr

Entity Type: 09

Trademark Details

Filing Date

March 23, 2021

Registration Date

Not Registered

Goods & Services

Medical and veterinary preparations and substances, namely, for the treatment of acetaminophen/paracetamol over dose, MCT8 deficiency, RTHb, oncological, neurological, endocrinological, metabolic, hematological, eye, autoimmune and inflammatory related diseases; vaccines; sanitary preparations for medical use; dietetic and nutritional preparations for medical use; diagnostic preparations for medical use; chemical reagents for medical use; diagnostic tests for medical use

Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical and chemical laboratories; scientific and industrial research relating to medicinal or veterinary practice; diagnostic and screening services relating to medicinal or veterinary research and development; informational services relating to medicinal or veterinary research and development

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 6, 2022 DENA
DEATH OF INTERNATIONAL REGISTRATION
Mar 5, 2022 DETH
REFUSAL PROCESSED BY IB
Dec 19, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 1, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 11, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 5, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 3, 2021 REPR